Hybrid Solutions
OnAsset offers enhanced, custom supply chain monitoring solutions to meet the specific challenges you face.
Sarclisa (isatuximab-irfc) for the Treatment of Multiple Myeloma
Sarclisa was approved by the US Food and Drug Administration (FDA) in March 2020. Credit: Sanofi-Aventis.
Learn more
Hover over the logos to learn more about the companies who made this project possible.
Close
-
OnAsset Intelligence
OnAsset’s SENTRY devices are widely used for real-time tracking and...
About
OnAsset’s SENTRY devices are widely used for real-time tracking and monitoring life sciences and pharmaceutical shipments around the globe.
FollowMake an Enquiry
-
Pilloxa
Pilloxa creates digital and remote solutions to optimise clinical trials...
About
Pilloxa creates digital and remote solutions to optimise clinical trials and patient support programmes through supporting medical adherence and patient retention.
FollowMake an Enquiry
-
MIT Optimal Sourcing Solutions
MIT Optimal Sourcing Solutions is a dedicated supplier of comparator...
About
MIT Optimal Sourcing Solutions is a dedicated supplier of comparator drugs, specialised in European Union (EU) open market solutions for clinical trials.
FollowMake an Enquiry